Drugs to combat HIV are about to become cheaper in developing countries. The
multinationals Glaxo Wellcome and Hoffmann-La Roche will supply drugs at cut
rates to Uganda, Côte d’Ivoire, Chile and Vietnam in a two-year pilot
initiative organised by the Joint UN Programme on HIV/AIDS. Virco, a Belgian
diagnostics company, will train local technicians to screen patients to work out
which drugs to use. “We want to demonstrate that it is workable and
sustainable,” says Joseph Saba, the initiative’s coordinator. The extent of the
discounts is still being worked out.
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
Are Neanderthals descendants of modern humans?
2
Collapse of key ocean current may release billions of tonnes of carbon
3
Exclusive report: Inside Chernobyl, 40 years after nuclear disaster
4
Beef is making a comeback – does it fit into a healthy diet?
5
Why is it so hard to change your mind?
6
The biggest threat to Chernobyl is no longer radiation
7
How autoimmune conditions can unexpectedly drive mental illness
8
Electric vehicle owners could earn thousands by supporting power grid
9
Surprising male G-spot found in most detailed study of the penis yet
10
The rise, the fall and the rebound of cyclic cosmology
